The role of neuroimaging in dementia

Clinics in Geriatric Medicine

Volumn 17, Issue 2, 2001, Pages 255-279

  DeCarli, Charles ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FOLLOW UP; REVIEW;

EID: 0035018202     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(05)70068-9     Document Type: Article

References (95)

1. Imaging in primary progressive aphasia
2. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
3. Coupling between cerebral blood flow, oxygen consumption, and glucose utilization: Its study with postron tomography
4. PET imaging of tangles and plaques in Alzheimer disease
5. 1H MR SPECTROSCOPY studies in vivo
6. Factors affecting the measurement of size and CT number in computed tomography
7. HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease
8. Inositol phosphates and cell signaling
9. Neurofibrillary pathology-correlation with hippocampal formation atrophy in Alzheimer disease
10. Evolution of the neuropathology of Alzheimer's disease
11. The aging brain and neurodegenerative disorders
12. MR imaging in autonomic failure
13. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
14. Evaluation of dementia: A systematic study of the usefulness of the American Academy of Neurology's Practice Parameters
15. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: A population based study
16. Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington's disease
17. The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease
18. A new method for measuring cranial cavity volume and its application to the assessment of cerebral atrophy at autopsy
19. Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients
20. Comparison of positron emission tomography, cognition and brain volume in Alzheimer's disease with and without severe white matter abnormalities
21. Critical analysis of the use of computer assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type
22. Predictors of brain morphology among the men of the NHLBI Twin Study
23. Discriminant analysis of MR imaging measures as a method to determine the presence of dementia of the Alzheirner type
24. The effect of white matter hyperintensity volume on brain structure, cognitive performance and cerebral metabolism in 51 healthy adults
25. Changes in brain weights during the span of human life: Relation of brain weights to body heights and body weights
26. The radiologic prediction of Alzheimer disease: The atrophic hippocampal formation
27. The apical artifact: Elevated attenuation values toward the apex of the skull
28. Basic principals of magnetic resonance imaging
29. Brain atrophy progression measured from registered serial MR imaging: Validation and application to Alzheimer's disease
30. Correlation between rates of brain atrophy and cognitive decline in AD
31. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease
32. The boundary shift integral: An accurate and robust measure of cerebral volume changes from registered repeat MR imaging
33. Receptor imaging by PET and SPECT: Focus on the opiate receptor
34. Clinical-neuropathological correlations in Alzheimer's disease and related dementias
35. Renal medullary organic osmolytes
36. Diagnostic criteria for Parkinson disease
37. CT diagnostic features of Alzheimer disease: Importance of the choroidal/hippocampal fissure complex
38. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
39. Diagnostic accuracy of single photon emission computed tomography in Alzheimer's disease
40. Medical temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MR imaging study
41. Magnetic resonance imaging of coricobasal degeneration
42. Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type: Longitudinal confirmation
43. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type
44. Evaluation of the brain by positron emission tomography
45. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia
46. Quantitation in positron emission computed tomography: 1. Effect of object size
47. Positron emission tomography: Principles and quantitation
48. Brain perfusion SPECT using an annular single crystal camera: Initial clinical experience
49. Quantification and analysis of positron emission tomography metabolic data
50. 1H MR SPECTROSCOPY study
51. Age, senile dementia and ventricular enlargement
52. Quantitation of rCBF by 99mTc-hexamethlypropyleneamine oxime single photon emission computed tomography combined with 133Xe CBF
53. The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using 1-123 IMPSPECT
54. Cerebral glucose metabolism in patients with frontotemporal dementia
55. Prediction of AD with MR imaging-base hippocampal volume in mild cognitive impairment
56. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease
57. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography
58. Preclinical prediction of Alzheimer's disease using SPECT
59. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia
60. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease
61. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease
62. The effect of computed tomography viewer controls on anatomical measurements
63. Statistical assessment of perceptual CT scan ratings in patients with Alzheimer type dementia
64. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease and dementia with Lewy bodies
65. The concept of coupling blood flow to brain function: Revision required?
66. Sensitivity, specificity and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias
67. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
68. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia
69. Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: Measurements with an image analyzer
70. Neuroimaging in the diagnosis of frontotemporal dementia
71. The molecular heterogeneity of protein kinase C and its implications for cellular regulation
72. Central nervous system findings in a tenth decade autopsy population
73. Abnormal brain glucose metabolism in Alzheimer's disease as measured by positron emission tomography
74. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E
75. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease
76. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Work Group
77. Differential diagnosis of Alzheimer's disease with PET
78. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population
79. Qualitative assessment of cerebral atrophy on MR imaging: Inter- and intra-observer reproducibility in dementia and normal aging
80. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
81. Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease
82. Clinical value of neuroimaging in the diagnosis of dementia: Sensitivitiy and specificity of regional cerebral metabolic and other parameters for early identification of Alzheimer's disease
83. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system
84. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
85. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes
86. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?
87. Detection, visualization and animation of abnormal anatomic structure with a deformable probabilistic brain atlas based on random vector field transformations
88. Diagnosing Alzheimer's disease in elderly, mildly demented patients: The impact of routine single photon emission computed tomography
89. Functional brain imaging with SPECT in normal aging and dementia
90. Correction of intensity non-uniformity in MR images of any orientation
91. Functional neuroimaging with single photon emission computed tomopgraphy (SPECT)
92. Progressive supranuclear palsy: MR imaging and pathological findings
93. Image quality in cranial computed tomography
94. The ventricular-brain ratio on computed tomography scans: Validity and proper use